Hakutulokset - Sara Bar‐Yehuda

  • Näytetään 1 - 6 yhteensä 6 tuloksesta
Tarkenna hakua
  1. 1
    Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor

    Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor Tekijä Gil Ohana, Sara Bar‐Yehuda, Faina Barer, Pnina Fishman

    Julkaistu 2000
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Pharmacological and therapeutic effects of A3 adenosine receptor agonists

    Pharmacological and therapeutic effects of A3 adenosine receptor agonists Tekijä Pnina Fishman, Sara Bar‐Yehuda, Bruce T. Liang, Kenneth A. Jacobson

    Julkaistu 2011
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    A3 Adenosine Receptor Activation in Melanoma Cells

    A3 Adenosine Receptor Activation in Melanoma Cells Tekijä Lea Madi, Sara Bar‐Yehuda, Faina Barer, Eti Ardon, Avivit Ochaion, Pnina Fishman

    Julkaistu 2003
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.

    The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Tekijä Pnina Fishman, Sara Bar‐Yehuda, Lea Madi, Lea Rath‐Wolfson, Avivit Ochaion, Shira Cohen, Ehud Baharav

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    The A3 Adenosine Receptor Is Highly Expressed in Tumor <b> <i>versus</i> </b> Normal Cells

    The A3 Adenosine Receptor Is Highly Expressed in Tumor <b> <i>versus</i> </b> Normal Cells Tekijä Lea Madi, Avivit Ochaion, Lea Rath‐Wolfson, Sara Bar‐Yehuda, Abigail Erlanger, Gil Ohana, Arie Harish, Ofer Merimski, Faina Barer, Pnina Fishman

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study

    CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study Tekijä Salomon M. Stemmer, Ofer Benjaminov, Gal Medalia, N.B. Ciuraru, Michael H. Silverman, Sara Bar‐Yehuda, Sari Fishman, Zivit Harpaz, Motti Farbstein, Shira Cohen, R. Patoka, Barak Singer, William Kerns, Pnina Fishman

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: